rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through ppar - and ppar -dependent phosphorylation of akt and enos罗格列酮恢复内皮功能障碍在代谢综合征大鼠模型通过ppar -和ppar端依赖一种蛋白激酶的磷酸化和以挪士.pdfVIP

  • 5
  • 0
  • 约7.43万字
  • 约 10页
  • 2017-09-01 发布于上海
  • 举报

rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through ppar - and ppar -dependent phosphorylation of akt and enos罗格列酮恢复内皮功能障碍在代谢综合征大鼠模型通过ppar -和ppar端依赖一种蛋白激酶的磷酸化和以挪士.pdf

rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through ppar - and ppar -dependent phosphorylation of akt and enos罗格列酮恢复内皮功能障碍在代谢综合征大鼠模型通过ppar -和ppar端依赖一种蛋白激酶的磷酸化和以挪士

Hindawi Publishing Corporation PPAR Research Volume 2011, Article ID 291656, 9 pages doi:10.1155/2011/291656 Research Article Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS Zhigang Zhao, Zhidan Luo, Peijian Wang, Jing Sun, Hao Yu, Tingbing Cao, Yinxing Ni, Jing Chen, Zhencheng Yan, Daoyan Liu, and Zhiming Zhu Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Med

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档